|
1
|
Jia Y, Jeng JM, Sensi SL and Weiss JH:
Zn2+ currents are mediated by calcium-permeable
AMPA/kainate channels in cultured murine hippocampal neurones. J
Physiol. 543:35–48. 2002.PubMed/NCBI
|
|
2
|
Koh JY and Choi DW: Zinc toxicity on
cultured cortical neurons: involvement of N-methyl-D-aspartate
receptors. Neuroscience. 60:1049–1057. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Palmiter RD and Findley SD: Cloning and
functional characterization of a mammalian zinc transporter that
confers resistance to zinc. EMBO J. 14:639–649. 1995.PubMed/NCBI
|
|
4
|
Rogers EE, Eide DJ and Guerinot ML:
Altered selectivity in an Arabidopsis metal transporter. Proc Natl
Acad Sci USA. 97:12356–12360. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vallee BL and Auld DS: Zinc coordination,
function, and structure of zinc enzymes and other proteins.
Biochemistry. 29:5647–5659. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vallee BL and Falchuk KH: The biochemical
basis of zinc physiology. Physiol Rev. 73:79–118. 1993.PubMed/NCBI
|
|
7
|
Wu X, Jin T, Wang Z, Ye T, Kong Q and
Nordberg G: Urinary calcium as a biomarker of renal dysfunction in
a general population exposed to cadmium. J Occup Environ Med.
43:898–904. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lui E, Fisman M, Wong C and Diaz F: Metals
and the liver in Alzheimer’s disease. An investigation of hepatic
zinc, copper, cadmium, and metallothionein. J Am Geriatr Soc.
38:633–639. 1990.
|
|
9
|
Panayi AE, Spyrou NM, Iversen BS, White MA
and Part P: Determination of cadmium and zinc in Alzheimer’s brain
tissue using inductively coupled plasma mass spectrometry. J Neurol
Sci. 195:1–10. 2002.
|
|
10
|
Lambert MP, Barlow AK, Chromy BA, et al:
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent
central nervous system neurotoxins. Proc Natl Acad Sci USA.
95:6448–6453. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Torreilles F and Touchon J: Pathogenic
theories and intrathecal analysis of the sporadic form of
Alzheimer’s disease. Prog Neurobiol. 66:191–203. 2002.PubMed/NCBI
|
|
12
|
Bressler JP, Olivi L, Cheong JH, Kim Y,
Maerten A and Bannon D: Metal transporters in intestine and brain:
their involvement in metal-associated neurotoxicities. Hum Exp
Toxicol. 26:221–229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jomova K and Valko M: Advances in
metal-induced oxidative stress and human disease. Toxicology.
283:65–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang LF, Yao TM, Zhu ZL, Wang C and Ji
LN: Impacts of Cd(II) on the conformation and self-aggregation of
Alzheimer’s tau fragment corresponding to the third repeat of
microtubule-binding domain. Biochim Biophys Acta. 1774:1414–1421.
2007.PubMed/NCBI
|
|
15
|
Danscher G, Jensen KB, Frederickson CJ, et
al: Increased amount of zinc in the hippocampus and amygdala of
Alzheimer’s diseased brains: a proton-induced X-ray emission
spectroscopic analysis of cryostat sections from autopsy material.
J Neurosci Methods. 76:53–59. 1997.PubMed/NCBI
|
|
16
|
Bush AI, Pettingell WH, Multhaup G, et al:
Rapid induction of Alzheimer A beta amyloid formation by zinc.
Science. 265:1464–1467. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu ST, Howlett G and Barrow CJ:
Histidine-13 is a crucial residue in the zinc ion-induced
aggregation of the A beta peptide of Alzheimer’s disease.
Biochemistry. 38:9373–9378. 1999.PubMed/NCBI
|
|
18
|
Danscher G, Stoltenberg M, Bruhn M,
Sondergaard C and Jensen D: Immersion autometallography:
histochemical in situ capturing of zinc ions in catalytic
zinc-sulfur nanocrystals. J Histochem Cytochem. 52:1619–1625. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jung KM, Astarita G, Yasar S, et al: An
amyloid beta(42)-dependent deficit in anandamide mobilization is
associated with cognitive dysfunction in Alzheimer’s disease.
Neurobiol Aging. May 3–2011.(Epub ahead of print).
|
|
20
|
Endres K and Fahrenholz F: The role of the
anti-amyloidogenic secretase ADAM10 in shedding the APP-like
proteins. Curr Alzheimer Res. May 23–2011.(Epub ahead of
print).
|
|
21
|
Hook VY and Reisine TD: Cysteine proteases
are the major beta-secretase in the regulated secretory pathway
that provides most of the beta-amyloid in Alzheimer’s disease: role
of BACE 1 in the constitutive secretory pathway. J Neurosci Res.
74:393–405. 2003.PubMed/NCBI
|
|
22
|
Iwata N and Saido TC: Amyloid-beta peptide
metabolism and Alzheimer’s disease. Nihon Yakurigaku Zasshi.
122:5–14. 2003.
|
|
23
|
Leissring MA, Farris W, Chang AY, et al:
Enhanced proteolysis of beta-amyloid in APP transgenic mice
prevents plaque formation, secondary pathology, and premature
death. Neuron. 40:1087–1093. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iwata N, Mizukami H, Shirotani K, et al:
Presynaptic localization of neprilysin contributes to efficient
clearance of amyloid-beta peptide in mouse brain. J Neurosci.
24:991–998. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marr RA, Rockenstein E, Mukherjee A, et
al: Neprilysin gene transfer reduces human amyloid pathology in
transgenic mice. J Neurosci. 23:1992–1996. 2003.PubMed/NCBI
|
|
26
|
Sakai A, Ujike H, Nakata K, et al:
Association of the neprilysin gene with susceptibility to
late-onset Alzheimer’s disease. Dement Geriatr Cogn Disord.
17:164–169. 2004.PubMed/NCBI
|
